COVID-19 guidance
Key COVID-19 guidance for community pharmacy
Key COVID-19 guidance for primary care
- Previous
- Next
Inhaler choice guideline
Information is intended for healthcare professionals only.
PCDE pharmacological management of type 2 diabetes
This succint summary highlights the treatment recommendations for type 2 diabetes by cardiovascular/renal disease or risk factor.
BSR giant cell arteritis guideline
This summary outlines the general principles of identifying and treating patients with giant cell arteritis in primary care and specialist settings. It is recommended that general practitioners refer patients with suspected giant cell arteritis to a clinician with appropriate specialist expertise.
COVID-19 personal protective equipment (PPE)
This revised guidance concerns use of personal protective equipment (PPE) by health and social care workers, in the context of the current COVID-19 pandemic.
PHE whooping cough vaccination in pregnancy guideline
A concise summary covering the pertussis vaccination programme for pregnant women.
GINA strategy 2020: assessing patients with asthma
This Guidelines summary outlines recommendations for assessing patients with asthma. Please refer to the full report for the complete set of recommendations.
Guidelines multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading a summary. Below is a list of the most recent sets of MCQs.
Educational resources
Supplements
Supplements are written by experts and typically discuss a piece of national guidance, pulling out key learning points for GPs.
Videos
Short 3–5 minute videos that may introduce a recently published guideline, discuss the implementation of a guideline in general practice, or highlight key recommendations for GPs or GP commissioners
Webinars
Webinars provide a 1-hour update from expert speakers on the latest evidence and guidance. Available live and on-demand.
